Projects per year
Fingerprint
Dive into the research topics where Marta Chesi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Preclinical studies for the immunoprevention of multiple myeloma
Bergsagel, P. P. L. (PI) & Chesi, M. (CoPI)
8/15/25 → 5/31/26
Project: Research project
-
preclinical optimization of BCMA directed T cell therapy
Chesi, M. (PI) & Bergsagel, P. P. L. (CoPI)
9/20/23 → 8/31/26
Project: Research project
-
Mayo Clinic Multiple Myeloma SPORE
Bergsagel, L. (PI), Braggio, E. D. (CoPI), Vachon, C. M. (CoPI), Chesi, M. (CoPI), Dueck, A. (CoPI), Fonseca, R. (CoPI), Geyer, S. (CoPI), Jelinek, D. F. (CoPI), Lacy, M. (CoPI), Stewart, A. K. (CoPI) & Lin, Y. Y. (CoPI)
9/1/15 → 8/31/26
Project: Research project
-
Credentialing a Genetically Engineered Clinically-Relevant Mouse Model of Multiple Myeloma
Chesi, M. (PI)
12/7/18 → 11/30/23
Project: Research project
-
Immunomodulatory Therapy of Multiple Myeloma with SMAC Mimetics
Chesi, M. (PI)
9/1/15 → 8/31/20
Project: Research project
-
An immunostimulatory CELMoD combination overcomes resistance to T-cell engagers caused by a high multiple myeloma burden
Meermeier, E. W., Pfeffer, K., Stein, C. K., Sharik, M. E., Du, M. T., Tafoya Alvarado, Y., Shi, C. X., Zhu, Y. X., Bergsagel, P. L. & Chesi, M., 2025, (Accepted/In press) In: Blood.Research output: Contribution to journal › Article › peer-review
-
A novel cereblon variant with both exon 8 and 10 deletions in newly diagnosed and relapsed multiple myeloma
Zhu, Y. X., Dutta, S., Ahmann, G. J., Bruins, L., Arribas, M., Chen, X., Polavarapu, A., Chapman, J., Lopez, I., Chesi, M., Bergsagel, P. L., Singharoy, A., Fonseca, R. & Rimsza, L. M., Aug 2025, In: Blood Neoplasia. 2, 3, 100099.Research output: Contribution to journal › Article › peer-review
Open Access -
A Phase I Clinical Study and In Vivo Findings with PT-112, a Novel Immunogenic Cell Death–Inducing Small Molecule, in Relapsed or Refractory Multiple Myeloma
Kourelis, T., Ailawadhi, S., Vogl, D. T., Gibson, S. E., Sharik, M. E., Du, M. T., Ames, T. D., Yim, C. Y., Baeck, J., Price, M. R., Jimeno, J. M., Chesi, M. & Leif Bergsagel, P., Nov 1 2025, In: Clinical Cancer Research. 31, 21, p. 4518-4528 11 p.Research output: Contribution to journal › Article › peer-review
-
B-cell–specific Wwox deletion promotes plasmablastic tumor development and proinflammatory signatures in myeloma model
Hussain, T., Bramble, M. D., Liu, B., Abba, M. C., Chesi, M. & Aldaz, C. M., Nov 2025, In: Blood Neoplasia. 2, 4, 100153.Research output: Contribution to journal › Article › peer-review
Open Access -
Exploring BCL2 regulation and upstream signaling transduction in venetoclax resistance in multiple myeloma: potential avenues for therapeutic intervention
Fonseca, R., Zhu, Y. X., Bruins, L. A., Ahmann, J., de Bonolo Campos, C., Braggio, E., Chen, X., Arribas, M., Darvish, S., Welsh, S., Meermeier, E., Mangalaparthi, K. K., Kandasamy, R. K., Ahmann, G., Wiedmeier-Nutor, J. E., Pandey, A., Chesi, M., Bergsagel, P. L. & Fonseca, R., Dec 2025, In: Blood cancer journal. 15, 1, 10.Research output: Contribution to journal › Article › peer-review
Open Access